CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Massively multiplexed nucleic acid detection with Cas13
-
April 29 2020
-
-
Source: Nature. 582(7811):277-282
[PDF-25.14 MB]
Details:
-
Alternative Title:Nature
-
Personal Author:
-
Description:The great majority of globally circulating pathogens go undetected, undermining patient care and hindering outbreak preparedness and response. To enable routine surveillance and comprehensive diagnostic applications, there is a need for detection technologies that can scale to test many samples| while simultaneously testing for many pathogens|. Here, we develop Combinatorial Arrayed Reactions for Multiplexed Evaluation of Nucleic acids (CARMEN), a platform for scalable, multiplexed pathogen detection. In the CARMEN platform, nanolitre droplets containing CRISPR-based nucleic acid detection reagents| self-organize in a microwell array| to pair with droplets of amplified samples, testing each sample against each CRISPR RNA (crRNA) in replicate. The combination of CARMEN and Cas13 detection (CARMEN-Cas13) enables robust testing of more than 4,500 crRNA-target pairs on a single array. Using CARMEN-Cas13, we developed a multiplexed assay that simultaneously differentiates all 169 human-associated viruses with at least 10 published genome sequences and rapidly incorporated an additional crRNA to detect the causative agent of the 2020 COVID-19 pandemic. CARMEN-Cas13 further enables comprehensive subtyping of influenza A strains and multiplexed identification of dozens of HIV drug-resistance mutations. The intrinsic multiplexing and throughput capabilities of CARMEN make it practical to scale, as miniaturization decreases reagent cost per test by more than 300-fold. Scalable, highly multiplexed CRISPR-based nucleic acid detection shifts diagnostic and surveillance efforts from targeted testing of high-priority samples to comprehensive testing of large sample sets, greatly benefiting patients and public health|.
-
Subjects:
-
Source:
-
Pubmed ID:32349121
-
Pubmed Central ID:PMC7332423
-
Document Type:
-
Funding:
-
Volume:582
-
Issue:7811
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
Supporting Files
-
gif 
jpeg 
gif 
jpeg 
gif 
jpeg 
gif 
jpeg 
gif 
jpeg 
gif 
gif 
jpeg 
gif 
jpeg 
gif 
jpeg 
gif 
jpeg 
xlsx 
pdf 
jpeg 
pdf 
xlsx 
xlsx 
xlsx 
xlsx 
xlsx 
xlsx 
xlsx 
gif 
jpeg 
gif 
xml 
jpeg 
gif 
jpeg 
gif 
jpeg
